beta

ANGO

AngioDynamics Inc.

Ango

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

09-27-2018 07-11-2018 03-29-2018 01-04-2018 09-28-2017 07-18-2017 03-30-2017 01-06-2017 10-05-2016
Actual EPS 0.16 0.2 0.25 0.16 0.12 0.19 0.19 0.19 0.17
Consensus EPS 0.18 0.21 0.2 0.17 0.16 0.16 0.15 0.16 0.13
Estimated EPS 0.18 0.21 0.2 0.17 0.16 0.16 0.15 0.16 0.13
Number of Estimates 2 2 2 3 3 3 3 4 4
EPS Surprise -$0.02 -$0.01 $0.05 -$0.01 -$0.04 $0.03 $0.04 $0.03 $0.04

Stats

Summary

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Market Cap: 632 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.angiodynamics.com

Shares Outstanding: 36.7 Million

Float: 33.1 Million

Dividend: 0.0 (0.0%)

Beta: 0.962127

Sector: Healthcare

Industry: Medical Instruments & Equipment

Short Interest (Jan 12, 2018): 2.1 Million

Ethical Flags

Longest drawdown: 796 trading days

From: 2015-01-29 To: 2018-04-10

Lowest Point:

AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-10-03 14:45:25:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-10-03 14:45:25:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-10-03 14:45:25:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-10-03 14:45:25:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-10-03 14:45:25:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-10-03 14:45:25:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics, Inc. (ANGO) CEO James Clemmer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-27 23:38:06:000

AngioDynamics, Inc. (ANGO) Q1 2019 Earnings Conference Call September 27, 2018 8:00 AM ET Executives James Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice President and General… read more...

AngioDynamics, Inc. (ANGO) CEO James Clemmer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-27 23:38:06:000

AngioDynamics, Inc. (ANGO) Q1 2019 Earnings Conference Call September 27, 2018 8:00 AM ET Executives James Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice President and General… read more...

AngioDynamics, Inc. (ANGO) CEO James Clemmer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-27 23:38:06:000

AngioDynamics, Inc. (ANGO) Q1 2019 Earnings Conference Call September 27, 2018 8:00 AM ET Executives James Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice President and General… read more...

AngioDynamics, Inc. (ANGO) CEO James Clemmer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-27 23:38:06:000

AngioDynamics, Inc. (ANGO) Q1 2019 Earnings Conference Call September 27, 2018 8:00 AM ET Executives James Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice President and General… read more...

AngioDynamics, Inc. (ANGO) CEO James Clemmer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-27 23:38:06:000

AngioDynamics, Inc. (ANGO) Q1 2019 Earnings Conference Call September 27, 2018 8:00 AM ET Executives James Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice President and General… read more...

AngioDynamics, Inc. 2019 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-09-27 13:03:52:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2019 Q1 earnings Read more … read more...

AngioDynamics Q1 non-GAAP EPS up 23%

via: SeekingAlpha at 2018-09-27 07:24:44:000

AngioDynamics ( ANGO ) Q1 results : Revenues: $85.3M (-0.1%). More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Read more … read more...

AngioDynamics misses by $0.02, beats on revenue

via: SeekingAlpha at 2018-09-27 07:01:13:000

AngioDynamics (NASDAQ: ANGO ): Q1 Non-GAAP EPS of $0.16 misses by $0.02 ; GAAP EPS of -$0.01. More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

AngioDynamics Reports Fiscal 2019 First Quarter Financial Results

via: Business Wire at 2018-09-27 07:00:00:000

Fiscal 2019 First Quarter Highlights Net sales of $85.3 million, flat versus prior year Gross margin expanded 380 basis points year over year to 52.1% GAAP EPS of $(0.01) per share; adjusted EPS of $0.16 per share Cash used in operations of $8.9 million; capital e… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-09-26 17:30:26:000

ACN , ANGO , CAG , CCL , CMD , MKC , RAD , SCHL For Seeking Alpha's full earnings season calendar, click here . More news on: Accenture plc, AngioDynamics, Inc., ConAgra Brands, Inc., Earnings news and commentary, , read more...

AngioDynamics to Present at the Cantor Global Healthcare Conference

via: Business Wire at 2018-09-19 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at the Can… read more...

AngioDynamics to Present at the Cantor Global Healthcare Conference

via: Business Wire at 2018-09-19 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at the Can… read more...

AngioDynamics to Present at the Cantor Global Healthcare Conference

via: Business Wire at 2018-09-19 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at the Can… read more...

AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018

via: Business Wire at 2018-09-13 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2019 before the market open… read more...

AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018

via: Business Wire at 2018-09-13 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2019 before the market open… read more...

AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018

via: Business Wire at 2018-09-13 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2019 before the market open… read more...

AngioDynamics to acquire RadiaDyne

via: SeekingAlpha at 2018-09-13 07:27:51:000

AngioDynamics (NASDAQ: ANGO ) agrees to acquire privately held RadiaDyne, a developer of dose monitoring technology for cancer patients, for an undisclosed sum. More news on: AngioDynamics, Inc., Healthcare stocks news, Merger & acquisition news, Read more … read more...

AngioDynamics to acquire RadiaDyne

via: SeekingAlpha at 2018-09-13 07:27:51:000

AngioDynamics (NASDAQ: ANGO ) agrees to acquire privately held RadiaDyne, a developer of dose monitoring technology for cancer patients, for an undisclosed sum. More news on: AngioDynamics, Inc., Healthcare stocks news, Merger & acquisition news, Read more … read more...

AngioDynamics to acquire RadiaDyne

via: SeekingAlpha at 2018-09-13 07:27:51:000

AngioDynamics (NASDAQ: ANGO ) agrees to acquire privately held RadiaDyne, a developer of dose monitoring technology for cancer patients, for an undisclosed sum. More news on: AngioDynamics, Inc., Healthcare stocks news, Merger & acquisition news, Read more … read more...

AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

via: Business Wire at 2018-09-13 07:00:00:000

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and de… read more...

AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

via: Business Wire at 2018-09-13 07:00:00:000

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and de… read more...

AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

via: Business Wire at 2018-09-13 07:00:00:000

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and de… read more...

AngioDynamics (ANGO) Presents at 2018 Wells Fargo Securities Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-09-06 15:21:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents at 2018 Wells Fargo Securities Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-09-06 15:21:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents at 2018 Wells Fargo Securities Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-09-06 15:21:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents at 2018 Wells Fargo Securities Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-09-06 15:21:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents at 2018 Wells Fargo Securities Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-09-06 15:21:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

I Got 43% Return On My Obesity-Themed Portfolio. Janus Henderson Investors Did Better With SLIM.

via: SeekingAlpha at 2018-08-27 11:39:03:000

Hey, lookit dat! I can make a comparison! I had an epiphany. In my last article I shot my mouth off about not having made any comparisons of the non-neg Efficient Frontier ((EF)) process against other methods. While strictly true, maybe that intent can be approached by comparing my Mot… read more...

I Got 43% Return On My Obesity-Themed Portfolio. Janus Henderson Investors Did Better With SLIM.

via: SeekingAlpha at 2018-08-27 11:39:03:000

Hey, lookit dat! I can make a comparison! I had an epiphany. In my last article I shot my mouth off about not having made any comparisons of the non-neg Efficient Frontier ((EF)) process against other methods. While strictly true, maybe that intent can be approached by comparing my Mot… read more...

I Got 43% Return On My Obesity-Themed Portfolio. Janus Henderson Investors Did Better With SLIM.

via: SeekingAlpha at 2018-08-27 11:39:03:000

Hey, lookit dat! I can make a comparison! I had an epiphany. In my last article I shot my mouth off about not having made any comparisons of the non-neg Efficient Frontier ((EF)) process against other methods. While strictly true, maybe that intent can be approached by comparing my Mot… read more...

AngioDynamics to Present at Two Investor Conferences in September

via: Business Wire at 2018-08-23 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that it will present at the following two investor conferences in September: A live webcast of each … read more...

AngioDynamics to Present at Two Investor Conferences in September

via: Business Wire at 2018-08-23 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that it will present at the following two investor conferences in September: A live webcast of each … read more...

AngioDynamics to Present at Two Investor Conferences in September

via: Business Wire at 2018-08-23 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that it will present at the following two investor conferences in September: A live webcast of each … read more...

FDA streamlines voluntary device malfunction reporting

via: SeekingAlpha at 2018-08-16 10:22:56:000

The FDA has finalized its program for device makers for the voluntary reporting of device malfunctions. Manufacturers will be allowed to report certain product glitches on a quarterly basis and in summary form for certain product codes, reducing the number of required reports by about two … read more...

FDA streamlines voluntary device malfunction reporting

via: SeekingAlpha at 2018-08-16 10:22:56:000

The FDA has finalized its program for device makers for the voluntary reporting of device malfunctions. Manufacturers will be allowed to report certain product glitches on a quarterly basis and in summary form for certain product codes, reducing the number of required reports by about two … read more...

FDA streamlines voluntary device malfunction reporting

via: SeekingAlpha at 2018-08-16 10:22:56:000

The FDA has finalized its program for device makers for the voluntary reporting of device malfunctions. Manufacturers will be allowed to report certain product glitches on a quarterly basis and in summary form for certain product codes, reducing the number of required reports by about two … read more...

AngioDynamics acquires sealant system using in lung biopsies

via: SeekingAlpha at 2018-08-15 07:39:27:000

AngioDynamics (NASDAQ: ANGO ) acquires the BioSentry Track Sealant System from privately held Surgical Specialties, LLC for an undisclosed sum. The product is used to minimize the occurrence of pneumothorax (collapsed lung), a common complication of CT-guided percutaneous lung biopsy. Mo… read more...

AngioDynamics Provides Updates on Oncology and Vascular Access Businesses

via: Business Wire at 2018-08-15 07:00:00:000

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today provided a corporate update on enhancements made to its Oncology business and acknowledged a recent, favorable U.S. Di… read more...

Delcath: A Potential 2,900% Share Count Increase Could Make The Stock Price Decline

via: SeekingAlpha at 2018-08-07 09:23:00:000

Delcath Systems, Inc. ( DCTH ) is a dangerous stock. The company's recent losses are worrying, but the main issue is the massive stock dilution. Amid stock splits, the company increased the share count in 2017 and continues to do so in 2018. A recent announcement shows that Delcath is giving f… read more...

Delcath: A Potential 2,900% Share Count Increase Could Make The Stock Price Decline

via: SeekingAlpha at 2018-08-07 09:23:00:000

Delcath Systems, Inc. ( DCTH ) is a dangerous stock. The company's recent losses are worrying, but the main issue is the massive stock dilution. Amid stock splits, the company increased the share count in 2017 and continues to do so in 2018. A recent announcement shows that Delcath is giving f… read more...

Delcath: A Potential 2,900% Share Count Increase Could Make The Stock Price Decline

via: SeekingAlpha at 2018-08-07 09:23:00:000

Delcath Systems, Inc. ( DCTH ) is a dangerous stock. The company's recent losses are worrying, but the main issue is the massive stock dilution. Amid stock splits, the company increased the share count in 2017 and continues to do so in 2018. A recent announcement shows that Delcath is giving f… read more...

AngioDynamics Slowly Building Confidence In Its Turnaround

via: SeekingAlpha at 2018-07-12 15:26:12:000

The current CEO of AngioDynamics ( ANGO ) has referred to his restructuring plan at times as fixing the plane while its flying, and thats not a bad description. Years of questionable management choices and changes in direction left AngioDynamics with a dated, not part… read more...

AngioDynamics Slowly Building Confidence In Its Turnaround

via: SeekingAlpha at 2018-07-12 15:26:12:000

The current CEO of AngioDynamics ( ANGO ) has referred to his restructuring plan at times as fixing the plane while its flying, and thats not a bad description. Years of questionable management choices and changes in direction left AngioDynamics with a dated, not part… read more...

AngioDynamics Slowly Building Confidence In Its Turnaround

via: SeekingAlpha at 2018-07-12 15:26:12:000

The current CEO of AngioDynamics ( ANGO ) has referred to his restructuring plan at times as fixing the plane while its flying, and thats not a bad description. Years of questionable management choices and changes in direction left AngioDynamics with a dated, not part… read more...

AngioDynamics, Inc (ANGO) CEO Jim Clemmer on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-07-11 14:56:08:000

AngioDynamics, Inc (ANGO) Q4 2018 Earnings Conference Call July 11, 2018 08:00 ET Executives Jim Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice President, General Counsel A… read more...

Midday Gainers / Losers (07/11/2018)

via: SeekingAlpha at 2018-07-11 12:42:53:000

Gainers: MDGS +79% . MYOS +42% . BIOC +28% . ACHV +24% . TKAT +18% . ACIU +15% . MYGN +15% . WMLP +14% . MTSL +14% . INTX +13% . More news on: Medigus Ltd, MYOS RENS Technology, Biocept, Inc., Stocks on the move, , Read more … read more...

AngioDynamics, Inc. 2018 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-07-11 12:10:48:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q4 earnings Read more … read more...

AngioDynamics down 12% post Q4 results

via: SeekingAlpha at 2018-07-11 11:29:52:000

AngioDynamics ( ANGO -12.2% ) reports Q4 Peripheral Vascular sales of $52.6M, down 2.4% Y/Y as growth in fluid management, angiographic catheters, AngioVac, ablation and Nanoknife product lines were more than offset by decline in venous insufficiency and thrombolytic businesses. More n… read more...

AngioDynamics misses by $0.01, misses on revenue

via: SeekingAlpha at 2018-07-11 07:01:31:000

AngioDynamics (NASDAQ: ANGO ): Q4 EPS of $0.20 misses by $0.01 . Revenue of $88.31M (+1.6% Y/Y) misses by $1.01M . Press Release More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, read more...

AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results

via: Business Wire at 2018-07-11 07:00:00:000

Fiscal 2018 Fourth Quarter Highlights Net sales of $88.3 million, an increase of 1.6% year over year Gross margin expanded 500 basis points year over year to 53.7% GAAP EPS of $0.06 per share; adjusted EPS of $0.20 per share Operating cash flow of $23.8 million; f… read more...

AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018

via: Business Wire at 2018-06-21 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2018 before the m… read more...

AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018

via: Business Wire at 2018-06-21 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2018 before the m… read more...

AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018

via: Business Wire at 2018-06-21 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2018 before the m… read more...

AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018

via: Business Wire at 2018-06-21 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2018 before the m… read more...

AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018

via: Business Wire at 2018-06-21 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2018 before the m… read more...

AngioDynamics (ANGO) Presents At 2018 UBS Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-05-22 13:48:40:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics to Present at Two Investor Conferences in May

via: Business Wire at 2018-04-10 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will present at the following two investor conferences in May: Conference: Deutsch… read more...

AngioDynamics to Present at Two Investor Conferences in May

via: Business Wire at 2018-04-10 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will present at the following two investor conferences in May: Conference: Deutsch… read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-03 08:44:12:000

EXACT Sciences (NASDAQ: EXAS ) upgraded to Buy at BTIG Research. More news on: EXACT Sciences Corporation, United Therapeutics Corporation, AngioDynamics, Inc., Healthcare stocks news, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-03 08:44:12:000

EXACT Sciences (NASDAQ: EXAS ) upgraded to Buy at BTIG Research. More news on: EXACT Sciences Corporation, United Therapeutics Corporation, AngioDynamics, Inc., Healthcare stocks news, Read more … read more...

AngioDynamics, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-04-02 13:09:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

AngioDynamics, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-04-02 13:09:06:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

AngioDynamics' (ANGO) CEO Jim Clemmer on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-29 12:02:06:000

AngioDynamics Inc. (ANGO) Q4 2017 Earnings Conference Call March 29, 2018 08:00 AM ET Executives Jim Clemmer - President and CEO Michael Greiner - Executive Vice President and CFO Steve Trowbridge - Senior Vice President, General Counsel Analysts Cecilia Furlong - Canaccord… read more...

AngioDynamics' (ANGO) CEO Jim Clemmer on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-29 12:02:06:000

AngioDynamics Inc. (ANGO) Q4 2017 Earnings Conference Call March 29, 2018 08:00 AM ET Executives Jim Clemmer - President and CEO Michael Greiner - Executive Vice President and CFO Steve Trowbridge - Senior Vice President, General Counsel Analysts Cecilia Furlong - Canaccord… read more...

AngioDynamics beats by $0.06, misses on revenue

via: SeekingAlpha at 2018-03-29 07:01:20:000

AngioDynamics (NASDAQ: ANGO ): Q3 EPS of $0.25 beats by $0.06 . More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

AngioDynamics beats by $0.06, misses on revenue

via: SeekingAlpha at 2018-03-29 07:01:20:000

AngioDynamics (NASDAQ: ANGO ): Q3 EPS of $0.25 beats by $0.06 . More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results

via: Business Wire at 2018-03-29 07:00:00:000

Fiscal 2018 Third Quarter Highlights Net sales of $83.9 million, a decrease of 2.0% year over year Gross margin expanded 300 basis points year over year to 54.2% GAAP EPS of $0.37; Adjusted EPS of $0.25 per share Announced the launch of a wireless ultrasound devic… read more...

AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results

via: Business Wire at 2018-03-29 07:00:00:000

Fiscal 2018 Third Quarter Highlights Net sales of $83.9 million, a decrease of 2.0% year over year Gross margin expanded 300 basis points year over year to 54.2% GAAP EPS of $0.37; Adjusted EPS of $0.25 per share Announced the launch of a wireless ultrasound devic… read more...

AngioDynamics (ANGO) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-28 13:23:01:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics (ANGO) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-28 13:23:01:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

AngioDynamics to Present at the Needham 17th Annual Healthcare Conference

via: Business Wire at 2018-03-15 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at … read more...

AngioDynamics to Present at the Needham 17th Annual Healthcare Conference

via: Business Wire at 2018-03-15 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at … read more...

AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018

via: Business Wire at 2018-02-27 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the third quarter of fiscal year 2018 before the mark… read more...

AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018

via: Business Wire at 2018-02-27 16:01:00:000

AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the third quarter of fiscal year 2018 before the mark… read more...

AngioDynamics to Present at the Barclays Global Healthcare Conference

via: Business Wire at 2018-02-15 08:00:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vic… read more...

FDA OKs accelerated approval pathway for AngioDynamics' NanoKnife for pancreatic cancer; shares up 1% after hours

via: SeekingAlpha at 2018-01-24 16:31:27:000

AngioDynamics (NASDAQ: ANGO ) is up 1% after hours in response to its announcement that the FDA has granted Expedited Access Pathway (EAP) status for its NanoKnife System for the treatment of Stage III (cancer has spread, but not metastasized) pancreatic cancer. More news on:… read more...

AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife® System for the Treatment of Stage III Pancreatic Cancer

via: Business Wire at 2018-01-24 16:01:00:000

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that the United States Food and Drug Administration (FDA) has granted the Expedited Access Pat… read more...

AngioDynamics: Stay Away

via: SeekingAlpha at 2018-01-23 13:03:11:000

AngioDynamics (NASDAQ: ANGO ) is a medical device supplier whose stock has been under significant pressure since is Q1 2018 report back in September (the company's fiscal year is staggered seven months from the calendar). This compares especially poorly to the broader market with the S&P 5… read more...

AngioDynamics (ANGO) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-01-11 12:49:36:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-01-05 08:34:15:000

AmerisourceBergen (NYSE: ABC ) initiated with Outperform rating and $105 (12% upside) price target by Evercore ISI. More news on: AmerisourceBergen Corporation, Arbutus Biopharma Corp, AxoGen, Inc., Healthcare stocks news, Read more … read more...

AngioDynamics' (ANGO) CEO Jim Clemmer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-01-04 11:44:06:000

AngioDynamics, Inc. (ANGO) Q2 2018 Earnings Conference Call January 4, 2018, 8:00 AM ET Executives Jim Clemmer - President and CEO Michael Greiner - Executive Vice President and CFO Steve Trowbridge - Senior Vice President, General Counsel Analysts Jason Mills - Canaccord G… read more...

AngioDynamics, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-01-04 08:01:46:000

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

AngioDynamics EPS in-line, misses on revenue

via: SeekingAlpha at 2018-01-04 07:01:49:000

AngioDynamics (NASDAQ: ANGO ): Q2 EPS of $0.16 in-line. More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results

via: Business Wire at 2018-01-04 07:00:00:000

Fiscal 2018 Second Quarter Highlights Net sales of $86.7 million, a decrease of 2.6% year over year U.S. GAAP EPS of $0.01; Adjusted EPS of $0.16 per share Operating cash flow of $10.2 million; free cash flow of $9.4 million AngioDynamics, Inc.(NASDAQ:ANGO… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-01-03 17:30:48:000

ANGO , LW , MON , RPM , WBA For Seeking Alpha's full earnings season calendar, click here . More news on: AngioDynamics, Inc., Lamb Weston Holdings, Inc., Monsanto Company, Earnings news and commentary, read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX